CoChat

Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis

Open access
Guzy, Robert D., Sharma, Bhumika, Bell, Eric, Chandel, Navdeep S., Schumacker, Paul T. · 2008 · Molecular and Cellular Biology

The DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index; 18 of the 61 sources its claims cite were checked for support.

Abstract

Mitochondrial complex II is a tumor suppressor comprised of four subunits (SdhA, SdhB, SdhC, and SdhD). Mutations in any of these should disrupt complex II enzymatic activity, yet defects in SdhA produce bioenergetic deficiency while defects in SdhB, SdhC, or SdhD induce tumor formation. The mechanisms underlying these differences are not known. We show that the inhibition of distal subunits of complex II, either pharmacologically or via RNA interference of SdhB, increases normoxic reactive oxygen species (ROS) production, increases hypoxia-inducible factor alpha (HIF-alpha) stabilization in an ROS-dependent manner, and increases growth rates in vitro and in vivo without affecting hypoxia-mediated activation of HIF-alpha. Proximal pharmacologic inhibition or RNA interference of complex II at SdhA, however, does not increase normoxic ROS production or HIF-alpha stabilization and results in decreased growth rates in vitro and in vivo. Furthermore, the enhanced growth rates resulting from SdhB suppression are inhibited by the suppression of HIF-1alpha and/or HIF-2alpha, indicating that the mechanism of SdhB-induced tumor formation relies upon ROS production and subsequent HIF-alpha activation. Therefore, differences in ROS production, HIF proliferation, and cell proliferation contribute to the differences in tumor phenotype in cells lacking SdhB as opposed to those lacking SdhA.

Overview

CoChat Summary

TL;DR

In multiple tumor cell lines and xenografts, suppressing the distal complex II subunit SdhB increased normoxic ROS and HIF-1α/HIF-2α stabilization, enhanced proliferation and tumor growth, whereas suppressing proximal SdhA did not increase ROS/HIF and reduced growth. The SdhB-driven growth phenotype required HIF-1α and/or HIF-2α, supporting an ROS-dependent pseudohypoxic mechanism for SdhB/C/D-linked tumorigenesis.

Key findings

  • Pharmacologic inhibition at SdhD with TTFA (200 µM) increased normoxic HIF-1α, HRE-luciferase activity, and ROS (roGFP, DHE, Mito-SOX); SdhA inhibitors 3-NPA (100 µM) and MMA (1 mM) did not, and blocked TTFA-induced HIF-1α stabilization.
  • Stable SdhB shRNA in 143B, A549, and Hep3B cells reduced complex II activity and increased normoxic HIF-1α/HIF-2α, VEGF mRNA, HRE-luciferase, and ROS; HIF stabilization was attenuated by ebselen (25 µM), Mito-Q (1 µM), or 3-NPA (100 µM).
  • SdhA shRNA reduced complex II activity but did not significantly increase normoxic HIF-1α or ROS and decreased in vitro growth; SdhB shRNA increased in vitro growth and xenograft tumor growth/mass, while SdhA shRNA tumors grew more slowly than wild-type or SdhB shRNA tumors.
  • In SdhB shRNA 143B cells, suppressing HIF-1α and/or HIF-2α significantly decreased in vitro growth, tumor growth, and tumor mass compared with dHIF control.

Methods

  • Used Hep3B, A549, and 143B cells with stable shRNA against SdhB or SdhA, plus retroviral HIF-1α/HIF-2α shRNA in SdhB shRNA 143B cells; pharmacologic agents included TTFA, 3-NPA, MA, MMA, DMS, ebselen, Mito-Q, and TBAP.
  • Measured complex II activity, HIF-1α/HIF-2α/VEGF by immunoblot, HRE-luciferase, ROS by roGFP, DHE, and Mito-SOX, in vitro growth, and nude mouse xenografts (1 × 10⁶ cells; monitored 25–35 days).
  • Compared results to wild-type/mock controls; densitometry and P < 0.05 significance were used.

Limitations

  • The paper states it cannot rule out that HIF accumulation with SdhD deficiency proceeds by a different mechanism than SdhB suppression, and that the results do not refute ROS production at SdhD via SdhB/C/D mutations.
  • The paper notes the H₂O₂-mediated succinate accumulation model is not inconsistent, but required high H₂O₂ (100–500 µM) and it is unclear whether such levels occur in mitochondria.
  • Evident from the text: findings rely on shRNA knockdown and pharmacologic inhibitors in three cell lines rather than patient-derived Sdh mutations, and no direct succinate measurements are reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/mcb.01338-07

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

12 Valid · 0 Not valid · 22 Not checked · 84 Own results and interpretations

65 more claims · 2 with their cited sources checked

Create a free account to see all 118 claims and to verify the 43 references still open.

See all claims — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 40
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 54 references

Cited by

Items 301–400 of 426

Metadata

Authors
Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T.
Affiliations
  • Department of Pediatrics, Division of Neonatology
  • Northwestern University (US)
Corresponding author
Schumacker, Paul T.
Venue
Molecular and Cellular Biology
Published
2008-01-01
Volume
28
Issue
2
Pages
718-731
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2149282639
Cited by
427
References
54
Citations by year
2026: 8 · 2025: 14 · 2024: 20 · 2023: 29 · 2022: 18 · 2021: 30 · 2020: 31 · 2019: 22 · 2018: 26 · 2017: 18 · 2016: 23 · 2015: 24 · 2014: 32 · 2013: 22 · 2012: 29
FWCI
7.19
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL 32646, HL079650, R01HL035440, R01HL079650, HL35440)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
succinate dehydrogenase, SDHB, SDHA, reactive oxygen species, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, tumor suppressor, carcinogenesis, cell proliferation
MeSH terms
Animals, Cell Transformation, Neoplastic, Humans, Iron-Sulfur Proteins, Male, Mice, Nude, Neoplasm Transplantation, Protein Binding, Succinate Dehydrogenase, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Protein Subunits, RNA Interference, Electron Transport Complex II, Cell Line, Tumor, Cell Proliferation, Mice, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.